ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Crescendo Biologics Limited

Crescendo Biologics Limited is an active company incorporated on 13 November 2007 with the registered office located in Cambridge, Cambridgeshire. Crescendo Biologics Limited was registered 18 years ago.
Status
Active
Active since 16 years ago
Company No
06425006
Private limited company
Age
18 years
Incorporated 13 November 2007
Size
Small
Turnover is under £15M
Balance sheet is under £7.5M
Confirmation
Submitted
Dated 30 June 2025 (4 months ago)
Next confirmation dated 30 June 2026
Due by 14 July 2026 (8 months remaining)
Last change occurred 4 months ago
Accounts
Submitted
For period 1 Jan ⟶ 31 Dec 2024 (1 year)
Accounts type is Total Exemption Full
Next accounts for period 31 December 2025
Due by 30 September 2026 (10 months remaining)
Learn more about Crescendo Biologics Limited
Contact Update Details
Address
50-60 Station Road
Cambridge
CB1 2JH
England
Address changed on 28 Nov 2024 (11 months ago)
Previous address was Meditrina Building Babraham Research Campus Cambridge CB22 3AT
Telephone
01223497140
Email
Available in Endole App
See All Contacts
People
Officers
9
Shareholders
67
Controllers (PSC)
1
Dr Igor Matushansky
Director • Doctor • American • Lives in United States • Born in Aug 1972
Eva-Lotta Coulter
Director • Swedish • Lives in England • Born in Jul 1959
Graziano Seghezzi
Director • Italian • Lives in France • Born in Aug 1969
Dr Marietta Wu
Director • American • Lives in China • Born in May 1968
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Ngenics Global Limited
Ip2ipo Services Ltd is a mutual person.
Active
Levicept Ltd
Dr Kevin Stuart Johnson is a mutual person.
Active
T-Therapeutics Limited
Theodora Harold is a mutual person.
Active
C Biologics Holdco Limited
Theodora Harold is a mutual person.
Active
C Biologics Newco Limited
Theodora Harold is a mutual person.
Active
Inhibitaxin Limited
Dr Kevin Stuart Johnson is a mutual person.
Dissolved
See All Mutual Companies
Brands
Crescendo Biologics
Crescendo Biologics is a private, clinical stage immuno-oncology company developing targeted T cell enhancing Humabody® therapeutics.
Microbiotica
Microbiotica is a clinical-stage biopharmaceutical company that develops live biotherapeutic products for immuno-oncology and inflammatory bowel disease based on microbiome science..
Financials
Net Assets, Total Assets & Total Liabilities (2016–2024)
Period Ended
31 Dec 2024
For period 31 Dec ⟶ 31 Dec 2024
Traded for 12 months
Cash in Bank
£2.51M
Decreased by £38.56M (-94%)
Turnover
£3.49M
Decreased by £2.96M (-46%)
Employees
52
Decreased by 8 (-13%)
Total Assets
£5.1M
Decreased by £42.4M (-89%)
Total Liabilities
-£1.23M
Decreased by £25.16M (-95%)
Net Assets
£3.87M
Decreased by £17.24M (-82%)
Debt Ratio (%)
24%
Decreased by 31.46% (-57%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
2 Months Ago on 3 Sep 2025
Confirmation Submitted
4 Months Ago on 14 Jul 2025
Own Shares Purchased
4 Months Ago on 1 Jul 2025
Shares Cancelled
4 Months Ago on 1 Jul 2025
Shares Cancelled
4 Months Ago on 1 Jul 2025
Shares Cancelled
4 Months Ago on 20 Jun 2025
Own Shares Purchased
4 Months Ago on 20 Jun 2025
Own Shares Purchased
7 Months Ago on 7 Apr 2025
Shares Cancelled
7 Months Ago on 7 Apr 2025
Igor Matushansky Resigned
10 Months Ago on 31 Dec 2024
Get Alerts
Get Credit Report
Discover Crescendo Biologics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 3 Sep 2025
Confirmation statement made on 30 June 2025 with updates
Submitted on 14 Jul 2025
Cancellation of shares. Statement of capital on 10 February 2025
Submitted on 1 Jul 2025
Change of share class name or designation
Submitted on 1 Jul 2025
Cancellation of shares. Statement of capital on 10 February 2025
Submitted on 1 Jul 2025
Statement of capital following an allotment of shares on 10 January 2025
Submitted on 1 Jul 2025
Purchase of own shares.
Submitted on 1 Jul 2025
Particulars of variation of rights attached to shares
Submitted on 30 Jun 2025
Change of share class name or designation
Submitted on 23 Jun 2025
Particulars of variation of rights attached to shares
Submitted on 23 Jun 2025
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs